GlassScriptPhysician profile
Binod P Shah
NPI 1346334604
$1,577.86
in general payments reported to CMS, 2019-2025
20 companies · $45.50 in 2025
The $45.50 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $161 · 2021: $101 · 2022: $185 · 2023: $257 · 2024: $438 · 2025: $45.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $386.48 | 2019-2024 | Senza |
| Si-Bone, INC. | $282.38 | 2023-2024 | |
| Abbvie INC. | $165.67 | 2022-2025 | Botox |
| Seapearl East, INC | $126.27 | 2024 | |
| Amarin Pharma, INC. | $124.97 | 2019 | |
| Abbott Laboratories | $83.39 | 2019-2020 | |
| Orthofix Medical, INC. | $61.33 | 2021 | |
| Pfizer INC. | $59.24 | 2019-2020 | |
| Bioventus LLC | $37.46 | 2019 | |
| Lundbeck LLC | $34.72 | 2024 | Vyepti |
| Pacira Pharmaceuticals Incorporated | $30.36 | 2023 | Iovera |
| Kowa Pharmaceuticals America, INC. | $27.26 | 2023 | Seglentis |
| Horizon Therapeutics Plc | $26.53 | 2021 | |
| Averitas Pharma INC. | $26.05 | 2023 | Qutenza |
| Allergan, INC. | $24.59 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epimed International, INC | $22.10 | 2019 | |
| Boston Scientific Corporation | $19.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.38 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.76 | 2019 | |
| Depuy Synthes Sales INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binod Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.